FindTrial
Sign In

The Screening and clinical study of the specific protein markers in the patients with severe pulmonary tuberculosis

The Screening and clinical study of the specific protein markers in the patients with severe pulmonary tuberculosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009913
Enrollment
Unknown
Registered
2016-11-18
Start date
2016-11-21
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis

Interventions

Gold Standard:Chest X-ray
Index test:distinct proteins

Sponsors

Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with tuberculosis.

Exclusion criteria

Exclusion criteria: Individuals with extrapulmonary TB, autoimmune diseases, chronic diseases, malignancies, receiving immunomodulatory therapy, or HIV infection were excluded.

Design outcomes

Primary

MeasureTime frame
TB protein biomarker;—

Countries

China

Contacts

Public ContactQi Li

Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute

autumnfairy@sina.com+86 010 89509013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026